MedPath
HSA Approval

HEMABATE INJECTION 250 mcg/ml

SIN06722P

HEMABATE INJECTION 250 mcg/ml

HEMABATE INJECTION 250 mcg/ml

November 29, 1991

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAMUSCULAR

Medical Information

G02AD04

carboprost

Manufacturer Information

PFIZER PRIVATE LIMITED

Pharmacia & Upjohn LLC

Active Ingredients

CARBOPROST TROMETHAMINE EQV CARBOPROST

250 mcg/ml

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HEMABATE INJECTION 250 mcg/ml - HSA Approval | MedPath